TAYSHA GENE THERAPIES INC (TSHA) Forecast, Price Target & Analyst Ratings

NASDAQ:TSHA • US8776191061

Current stock price

4.53 USD
-0.05 (-1.09%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TAYSHA GENE THERAPIES INC (TSHA).

Forecast Snapshot

Consensus Price Target

Price Target
$11.22
+ 147.68% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.10
Revenue Estimate
1.031M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$11.22
Upside
+ 147.68%
From current price of $4.53 to mean target of $11.22, Based on 20 analyst forecasts
Low
$7.07
Median
$11.22
High
$19.95

Price Target Revisions

1 Month
0.00%
3 Months
4.05%

Price Target Summary

20 Wall Street analysts provided a forecast for the next 12 months for TSHA. The average price target is 11.22 USD. This implies a price increase of 147.68% is expected in the next year compared to the current price of 4.53.
The average price target has been revised upward by 4.05% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

TSHA Current Analyst RatingTSHA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

TSHA Historical Analyst RatingsTSHA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
85.00%
TSHA was analyzed by 20 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about TSHA.
In the previous month the buy percentage consensus was at a similar level.
TSHA was analyzed by 20 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-19Chardan CapitalMaintains Buy -> Buy
2026-03-19NeedhamMaintains Buy -> Buy
2026-03-03NeedhamReiterate Buy -> Buy
2026-01-06Chardan CapitalMaintains Buy -> Buy
2026-01-05Wells FargoMaintains Overweight -> Overweight
2025-11-05CitizensMaintains Market Outperform -> Market Outperform
2025-11-05Chardan CapitalMaintains Buy -> Buy
2025-10-21Raymond JamesInitiate Strong Buy
2025-10-17Chardan CapitalMaintains Buy -> Buy
2025-10-17NeedhamReiterate Buy -> Buy
2025-10-02NeedhamMaintains Buy -> Buy
2025-10-02BairdMaintains Outperform -> Outperform
2025-08-13Wells FargoMaintains Overweight -> Overweight
2025-08-13Canaccord GenuityMaintains Buy -> Buy
2025-08-12Chardan CapitalMaintains Buy -> Buy
2025-07-11B of A SecuritiesInitiate Buy
2025-07-01NeedhamReiterate Buy -> Buy
2025-06-10NeedhamReiterate Buy -> Buy
2025-06-03Canaccord GenuityMaintains Buy -> Buy
2025-06-02NeedhamReiterate Buy -> Buy
2025-05-29Chardan CapitalMaintains Buy -> Buy
2025-05-29JMP SecuritiesMaintains Market Outperform -> Market Outperform
2025-05-16Canaccord GenuityMaintains Buy -> Buy
2025-04-28Cantor FitzgeraldReiterate Overweight -> Overweight
2025-04-28JMP SecuritiesReiterate Market Outperform -> Market Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.10
Revenue Estimate
1.031M
Revenue Q2Q
-55.21%
EPS Q2Q
-24.26%
Number of Analysts
13

Next Earnings Revisions

Revenue (1 Month)
-8.33%
Revenue (3 Months)
-8.33%
EPS (1 Month)
-1.21%
EPS (3 Months)
0.54%

Next Earnings Summary

TSHA is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is -0.1 USD and the consensus revenue estimate is 1.03M USD.
The next earnings revenue estimate has been revised downward by 8.33% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
TSHA revenue by date.TSHA revenue by date.
15.451M
518.04%		8.333M
-46.07%		9.773M
17.28%		4.545M
-53.49%		33.531M
637.76%		158.18M
371.74%		505.18M
219.37%		989.93M
95.96%		1.38B
39.40%		1.746B
26.52%		1.981B
13.46%
EBITDA
YoY % growth
TSHA ebitda by date.TSHA ebitda by date.
-70.003M
43.93%		-85.376M
-21.96%		-109.353M
-28.08%		-154.261M
-41.07%		-171.212M
-10.99%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
TSHA ebit by date.TSHA ebit by date.
-71.374M
43.37%		-86.621M
-21.36%		-110.498M
-27.56%		-152.25M
-37.79%		-159.387M
-4.69%		-81.245M
49.03%		161.52M
298.81%		492.44M
204.88%		741.29M
50.53%		978.76M
32.03%		1.116B
14.02%
Operating Margin
TSHA operating margin by date.TSHA operating margin by date.
-461.94%-1,039.49%-1,130.65%-3,349.84%-475.34%-51.36%31.97%49.74%53.72%56.06%56.34%
EPS
YoY % growth
TSHA eps by date.TSHA eps by date.
0.13
104.15%		-0.36
-376.92%		-0.34
5.56%		-0.44
-29.08%		-0.53
-19.93%		-0.17
67.69%		0.52
405.94%		1.21
132.35%		1.77
46.41%		2.03
14.70%		2.39
17.59%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.10
-24.26%		-0.10
-16.22%		-0.11
-20.54%		-0.11
-41.53%		-0.13
-27.23%		-0.13
-22.87%		-0.11
-3.42%		-0.09
22.52%
Revenue
Q2Q % growth		1.031M
-55.21%		1.031M
-48.09%		1.031M1.031M
-81.20%		1.02M
-1.07%		1.02M
-1.07%		34.805M
3,275.85%		81.213M
7,777.11%
EBITDA
Q2Q % growth		-35.56M
-68.23%		-38.109M
-45.49%		-40.657M
-22.54%		-42.185M
-55.35%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-35.356M
-65.05%		-36.845M
-37.72%		-39.066M
-14.82%		-40.679M
-43.74%		-45.5M
-28.69%		-46.519M
-26.26%		-39.432M
-0.94%		-28.247M
30.56%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

TSHA Yearly Revenue VS EstimatesTSHA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
TSHA Yearly EPS VS EstimatesTSHA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
14.47%
EPS Next 5 Year
40.91%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
187.84%
Revenue Next 5 Year
172.13%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

TAYSHA GENE THERAPIES INC / TSHA Forecast FAQ

What is the average price target for TAYSHA GENE THERAPIES INC (TSHA) stock?

20 analysts have analysed TSHA and the average price target is 11.22 USD. This implies a price increase of 147.68% is expected in the next year compared to the current price of 4.53.

Can you provide the upcoming earnings date for TAYSHA GENE THERAPIES INC?

TAYSHA GENE THERAPIES INC (TSHA) will report earnings on 2026-05-13.

What are the consensus estimates for TSHA stock next earnings?

The consensus EPS estimate for the next earnings of TAYSHA GENE THERAPIES INC (TSHA) is -0.1 USD and the consensus revenue estimate is 1.03M USD.

What is the expected long term growth rate for TSHA stock?

The expected long term growth rate for TAYSHA GENE THERAPIES INC (TSHA) is 187.84%.